Apeloa Pharmaceutical Co.,Ltd
000739
Rangering i aksjer
#4311
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Aksjekurs
$3.17
Markedsverdi
$3.67B
Endring (1 dag)
0.76%
Endring (1 år)
40.57%
Land
CN
Handel Apeloa Pharmaceutical Co.,Ltd (000739)
Kategori
Healthcare
Utbyttehistorikk for Apeloa Pharmaceutical Co.,Ltd (000739)
Apeloa Pharmaceutical Co.,Ltd (aksjesymbol: 000739) har gitt totalt 24 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $2.79
Utbytteavkastning (TTM): 0.0158
Summen av alle utbytter (justert for aksjesplitt): $2.79
Utbytteavkastning (TTM): 0.0158
Utbyttebetalinger for Apeloa Pharmaceutical Co.,Ltd (000739) fra 1998 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $0.139 | -80.27% |
| 2025 | $0.7045 | 122.31% |
| 2024 | $0.3169 | 6.70% |
| 2023 | $0.297 | 4.21% |
| 2022 | $0.285 | 17.28% |
| 2021 | $0.243 | 47.27% |
| 2020 | $0.165 | 50.00% |
| 2019 | $0.11 | 69.23% |
| 2018 | $0.065 | -5.80% |
| 2017 | $0.069 | 25.45% |
| 2016 | $0.055 | -35.29% |
| 2015 | $0.085 | 750.00% |
| 2014 | $0.01 | 29.87% |
| 2011 | $0.0077 | 0.00% |
| 2010 | $0.0077 | 0.00% |
| 2009 | $0.0077 | -39.84% |
| 2007 | $0.0128 | 0.00% |
| 2006 | $0.0128 | 24.27% |
| 2005 | $0.0103 | 0.00% |
| 2004 | $0.0103 | 0.00% |
| 2003 | $0.0103 | -63.86% |
| 1998 | $0.0285 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $0.139 | -80.27% |
| 2025 | $0.7045 | 122.31% |
| 2024 | $0.3169 | 6.70% |
| 2023 | $0.297 | 4.21% |
| 2022 | $0.285 | 17.28% |
| 2021 | $0.243 | 47.27% |
| 2020 | $0.165 | 50.00% |
| 2019 | $0.11 | 69.23% |
| 2018 | $0.065 | -5.80% |
| 2017 | $0.069 | 25.45% |
| 2016 | $0.055 | -35.29% |
| 2015 | $0.085 | 750.00% |
| 2014 | $0.01 | -50.00% |
| 2011 | $0.02 | 0.00% |
| 2010 | $0.02 | 0.00% |
| 2009 | $0.02 | -60.00% |
| 2007 | $0.05 | 0.00% |
| 2006 | $0.05 | 0.00% |
| 2005 | $0.05 | 0.00% |
| 2004 | $0.05 | 0.00% |
| 2003 | $0.05 | -83.33% |
| 1998 | $0.3 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 39.00% |
IN
|
